Could a malaria drug help clear HPV in women with HIV?
NCT ID NCT06519994
First seen Nov 20, 2025 · Last updated May 25, 2026 · Updated 23 times
Summary
This study tested whether artesunate vaginal inserts, a medicine used for malaria, can help clear HPV after standard cervical precancer treatment in women living with HIV. 120 women used the inserts or a placebo for 5 days on, 1 week off, repeated 3 times. The goal was to see if the artesunate group had higher HPV clearance at 6 months, and if the treatment was safe and easy to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lumumba Sub-County Hospital KEMRI- Research Care Training Program (RCTP) Building
Kisumu, 614-40100, Kenya
Conditions
Explore the condition pages connected to this study.